Analysis of variability in interpretation of spirometric tests

Respiration

Volumn 63, Issue 3, 1996, Pages 131-136

  Quadrelli, Silvia A ^a   Roncoroni, A J ^a   Porcel, G ^a  

^a INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

Author keywords

Asthma; Bronchodilator response; Chronic obstructive; Pulmonary disease; Spirometry

Indexed keywords

BRONCHODILATING AGENT;

AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FORCED EXPIRATORY VOLUME; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; SPIROMETRY;

AIRWAY OBSTRUCTION; ASTHMA; BRONCHODILATOR AGENTS; DATA COLLECTION; FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES, OBSTRUCTIVE; OBSERVER VARIATION; SPIROMETRY; TERMINOLOGY; VITAL CAPACITY;

EID: 0029985587     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000196532     Document Type: Article

References (28)

1. American Thoracic Society: Medical Section of the American Lung Association: Lung function testing: Selection of reference values and interpretative strategies. Am Rev Respir Dis 1991: 144:1202-1218.
2. Quanjer PhJ. Tammeling GJ, Cotes JE, Pedersen OF. Pcslin R. Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests. European Community for Coal and Steel. Eur Respir J 1993:6(suppl 16):5-40.
3. Cary J. Huseby J. Culver B, Kosankc C Jr: Variability in interpretation of pulmonary function tests. Chest 1979:76:389-390.
4. Eliasson O, Degraff AC Jr: The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Am Rev Respir Dis 1985:132:858-864.
5. Quadrelli SA, Montic IGC. Roncoroni AJ: Análisis de los factores de error en la espirometría. Medicina 1994:54:69-81.
6. Glindmeycr HW. Joncs RN. Barkman HW. Weill H: Spirometry: Quantitative test criteria and test acceptability. Am Rev Respir Dis 1987;136:449-452.
7. Colp CR: Interprétât ion of pulmonary function tests. Chest 1979:76:377-378.
8. Roncoroni AJ: Advances in bronchial physio-pathology. Excerpta Med Int Cong Ser Allergy Clin Immunol 1976;414:301-305.
9. Mendella LA. Manfrcda J. Warren CPW. An-thonisen NR: Steroid response in stable chronic obstructive pulmonary disease. Ann intent Med 1982:96:17-21.
10. −airflow obstruction. Ann Intern Med 1980:92:758-761.
11. Detcls R, Tashkin DP. Simmons MS: The UCLA population studies of chronic obstructive respiratory disease. 5. Agreement and disagreement of tests in identifying abnormal lung function. Chest 1982:82:630-638.
12. Ellis JH Jr. Perera SP. Levin DC: A computer program for calculation and interpretation of pulmonary function studies. Chest 1975:68: 209-213.
13. Harbcr P. Tockman M: Defining ‘disease’ in epidemiologic studies on pulmonary function: Percent of predicted or difference from predicted? Bull Eur Physiopathol Respir 1982:18: 819-828.
14. Miller MR, Pincock AC: Predicted values: How should we use them? Thorax 1988:43: 265-267.
15. Sobol BJ. Park SS. Emirgil C: Relative value of various spiroinetric tests in the early detection of chronic obstructive pulmonary disease. Am Rev Respir Dis 1973:107:753-762.
16. Quadrelli SA. Montic IGC. Roncoroni AJ: Espirometría: determinación del valor del límite inferior normal. Medicina 1993:53:36.
17. Roncoroni AJ, Goldman E. Puy RJM: Adelantos en el estudio de la mecánica respiratoria. Medicina 1974:34:374-392.
18. Roncoroni AJ: La pequeña vía aérea. Medicina 1976:36:347-363.
19. ACCP Committee on Pulmonary Physiology: Grading of pulmonary function by means of pulmonary function tests. Dis Chest 1967;52: 270-271.
20. Gaeasler EA, Wright GW: Evaluation of respiratory impairment. Arch Environ Health 1966: 12:146.
21. Kanner RE. Morris AH: Clinical Pulmonary Function Testing. A Manual of Uniform Laboratory Procedures for the Intermountain Area. Salt Lake City. Intermountain Thoracic Society, 1975.
22. Brand PL. Quanjer PH. Postma DS. Kerstjens HAM. Kortncr GH. Derhuizan PNR, Sluiter HJ: Interpretation of bronchodilator response in patients with obstructive airways disease. Thorax 1992:47:429-436.
23. Dompeling E. Van Schayck CP. Molema J. Fol-gering H. van Grunsven PM, van Weel C: A comparison of 6 different ways of expressing the bronchodilator response in asthma and COPD: reproducibility and dependence of pre-brorchodilator FEV1. Eur Respir J 1992;5: 975-981.
24. Quadrelli SA. Roncoroni AJ. Montic IGC: Respuesta a broncodilatadores en pacientes con asma bronquial. Medicina 1994:54:311-318.
25. Berger R. Smith D: Acute postbronchodilator changes in pulmonary function parameters in patients with chronic airways obstruction. Chest 1988:93:541-546.
26. Ligtht RW. Conrad SA, George RB: The one best for evaluating the effects of bronchodilator therapy. Chest 1977;72:512-516.
27. Meslier N. Racineux J. Six P, Lockhart A: Diagnostic value of reversibility to separate asthma from chronic bronchitis. Eur Respir J 1989;2:497-505.
28. Harf A: How to express the reversibility of bronchial obstruction? Eur Resp J 1992:5:919-920.